Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF- 7ras tumors by sodium phenylacetate and tamoxifen combination

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1023-1029

  Adam, Liana ^a,c   Crépin, Michel ^b   Israél, Lucien ^a  

^a Inst d'Oncol Cell et Molec Hum   (France)

^b SMBH   (France)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLACETATE SODIUM; PHENYLACETIC ACID DERIVATIVE; PROTEIN BCL 2; TAMOXIFEN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ADENOCARCINOMA; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; DRUG SYNERGISM; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GENES, RAS; GROWTH INHIBITORS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; ONCOGENE PROTEIN P21(RAS); PHENYLACETATES; PROTO-ONCOGENE PROTEINS C-BCL-2; TAMOXIFEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 1842413054     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Soule, H. D., Vasquez, J., Long, A., Albert, S., and Brennan, M. J. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973.
2. Lippman, M. E., Bolan, G., and Huff, K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term culture. Cancer Res., 36: 4610-4618, 1976.
3. Dickson, R. B., and Lippman, M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr. Rev., 8: 29-43, 1987.
4. Darbre, P., Yates, Y., Curtis, S., and King, R. B. Effect of estradiol on human breast cancer cells in culture. Cancer Res., 43: 349-354, 1983.
5. Osborne, C. K., Hobbs, K., and Clark, G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res., 45: 584-590, 1985.
6. H DNA into MCF7 cells bypasses their dependence on estrogen for tumorigenicity. Science (Washington DC), 228: 725-728, 1985.
7. Sonnenschein, C., Papendorp, J. T., and Soto, A. M. Estrogenic effect of tamoxifen and its derivations on the proliferation of MCF-7 human breast tumor cells. Life Sci., 37: 387-394, 1985.
8. Thompson, E. W., Reich, R., Shima, T. B., Albini, A., Graf, J., Martin, G. R., Dickson, R. B., and Lippman, M. E. Differential regulation of growth and invasiveness of MCF7 breast cancer cells by antiestrogens. Cancer Res., 48: 6764-6768, 1988.
9. Albini, A., Graf, J. G., Kitten, G. T., Kleinman, H. K., Martin, G. R., Veillette, A., and Lippman, M. E. 17β-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane. Proc. Natl. Acad. Sci. USA, 83: 8182-8186, 1986.
10. H Cancer Res., 50: 67-71, 1990.
11. Adam, L., Crépin, M., Savin, C., and Israël, L. Sodium phenylacetate induces growth inhibition and Bcl-2 down-regulation and apoptosis in MCF7ras cells in vitro and in nude mice. Cancer Res., 55: 5156-5160, 1995.
12. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. Detection of DNA strands breaks in individual apoptotic cells by in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53: 1945-1951, 1993.
13. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M., Lassota, P., and Traganos. F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
14. Gottardis, M. M., and Jordan, V. C. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res., 48: 5183-5189, 1988.
15. Legault-Poisson, S., Jolivet, J., Poisson, R., Beretta-Picoli, M., and Band, P. R. Tamoxifen-induced tumor stimulation and withdrawal response. Cancer Treat. Rep., 63: 1839-1841, 1979.
16. Reddel, R. R., and Sutherland, R. L. Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. Eur. J. Cancer Clin. Oncol., 20: 1419-1428, 1984.
17. Tonetti, D. A., and Jordan, C. Possible mechanisms in the emergence of tamoxifenresistant breast cancer. Anti-Cancer Drugs, 6: 498-507, 1995.
18. ras isoprenylation and phenotypic reversion. Int. J. Cancer. 63: 124-129, 1995.
19. Nunez, G., London, L., Hockenberry, D., Alexander, M., McKearn, J. P., and Korsmeyer, S. J. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor deprived hematopoetic cell lines. J. Immunol., 144: 3602-3610, 1990.
20. Harrington, E. A., Bennett, M. E. R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
21. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of cancer agents. Cell, 74: 957-967, 1993.
22. Walton, W. I., Whysong, D., O'Conner, P. M., Hockenberry, D., and Korsmeyer, S. J. Constitutive expression of human Bcl-2 modulates nitrogen mustard and campothecin-induced apoptosis. Cancer Res., 53: 1853-1861, 1993.
23. Wang, T. T. Y., and Phang, J. Effects on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res., 55: 2487-2489, 1995.
24. Teixeira, C., Reed, J. C., and Prart, M. A. C. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res., 55: 3902-3907, 1995.
25. Samid, D., Shac, S., and Sherman, L. T. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res., 52: 1988-1992, 1992.